Europlasma (France) Buy Hold or Sell Recommendation
ALEUP Stock | EUR 0.03 0.0008 2.35% |
Assuming the 90 days trading horizon and your above-average risk tolerance, our recommendation regarding Europlasma SA is 'Strong Sell'. A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Europlasma SA given historical horizon and risk tolerance towards Europlasma. When Macroaxis issues a 'buy' or 'sell' recommendation for Europlasma SA, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Europlasma Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as Europlasma and provide practical buy, sell, or hold advice based on investors' constraints. Europlasma SA. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
Europlasma |
Execute Europlasma Buy or Sell Advice
The Europlasma recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Europlasma SA. Macroaxis does not own or have any residual interests in Europlasma SA or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Europlasma's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Out of control | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Fairly Valued | Details | |
Odds Of Distress | Below Average | Details | |
Economic Sensitivity | Moves completely opposite to the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Europlasma Trading Alerts and Improvement Suggestions
Europlasma SA generated a negative expected return over the last 90 days | |
Europlasma SA has high historical volatility and very poor performance | |
Europlasma SA has some characteristics of a very speculative penny stock | |
Europlasma SA has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations | |
Europlasma SA has accumulated 2.92 M in total debt with debt to equity ratio (D/E) of 769.6, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Europlasma SA has a current ratio of 0.4, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Europlasma until it has trouble settling it off, either with new capital or with free cash flow. So, Europlasma's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Europlasma SA sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Europlasma to invest in growth at high rates of return. When we think about Europlasma's use of debt, we should always consider it together with cash and equity. | |
The entity reported the revenue of 9.8 M. Net Loss for the year was (12.67 M) with profit before overhead, payroll, taxes, and interest of 5.65 M. | |
Europlasma SA has accumulated about 3.92 M in cash with (18.21 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.02. |
Europlasma Returns Distribution Density
The distribution of Europlasma's historical returns is an attempt to chart the uncertainty of Europlasma's future price movements. The chart of the probability distribution of Europlasma daily returns describes the distribution of returns around its average expected value. We use Europlasma SA price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Europlasma returns is essential to provide solid investment advice for Europlasma.
Mean Return | -2.52 | Value At Risk | -10.07 | Potential Upside | 4.76 | Standard Deviation | 10.21 |
Return Density |
Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Europlasma historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Europlasma Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Europlasma or Commercial Services & Supplies sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Europlasma's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Europlasma stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -2.11 | |
β | Beta against Dow Jones | -3.46 | |
σ | Overall volatility | 10.14 | |
Ir | Information ratio | -0.26 |
Europlasma Volatility Alert
Europlasma SA is displaying above-average volatility over the selected time horizon. Europlasma SA is a penny stock. Although Europlasma may be in fact a good investment, many penny stocks are subject to artificial price hype. Make sure you completely understand the upside potential and downside risk of investing in Europlasma SA. We encourage investors to look for signals such as message board hypes, claims of breakthroughs, email spams, sudden volume upswings, and other similar hype indicators. We also encourage traders to check biographies and work history of company officers before investing in instruments with high volatility. You can indeed make money on Europlasma instrument if you perfectly time your entry and exit. However, remember that penny stocks that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Europlasma Fundamentals Vs Peers
Comparing Europlasma's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Europlasma's direct or indirect competition across all of the common fundamentals between Europlasma and the related equities. This way, we can detect undervalued stocks with similar characteristics as Europlasma or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Europlasma's fundamental indicators could also be used in its relative valuation, which is a method of valuing Europlasma by comparing valuation metrics with those of similar companies.
Better Than Average | Worse Than Average | Compare Europlasma to competition |
Fundamentals | Europlasma | Peer Average |
Return On Equity | -1.1 | -0.31 |
Return On Asset | -0.19 | -0.14 |
Profit Margin | (0.27) % | (1.27) % |
Operating Margin | (0.84) % | (5.51) % |
Current Valuation | 6.76 M | 16.62 B |
Shares Outstanding | 5.59 M | 571.82 M |
Price To Earning | (0.93) X | 28.72 X |
Price To Book | 0.26 X | 9.51 X |
Price To Sales | 0.55 X | 11.42 X |
Revenue | 9.8 M | 9.43 B |
Gross Profit | 5.65 M | 27.38 B |
EBITDA | (4.02 M) | 3.9 B |
Net Income | (12.67 M) | 570.98 M |
Cash And Equivalents | 3.92 M | 2.7 B |
Cash Per Share | 0.02 X | 5.01 X |
Total Debt | 2.92 M | 5.32 B |
Debt To Equity | 769.60 % | 48.70 % |
Current Ratio | 0.41 X | 2.16 X |
Book Value Per Share | 324.39 X | 1.93 K |
Cash Flow From Operations | (18.21 M) | 971.22 M |
Earnings Per Share | (4,055) X | 3.12 X |
Target Price | 0.3 | |
Number Of Employees | 126 | 18.84 K |
Beta | 0.72 | -0.15 |
Market Capitalization | 9.33 M | 19.03 B |
Total Asset | 40.44 M | 29.47 B |
Retained Earnings | (57 M) | 9.33 B |
Working Capital | (9 M) | 1.48 B |
Current Asset | 20 M | 9.34 B |
Current Liabilities | 29 M | 7.9 B |
Z Score | 0.4 | 8.72 |
Net Asset | 40.44 M |
Europlasma Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Europlasma . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Europlasma Buy or Sell Advice
When is the right time to buy or sell Europlasma SA? Buying financial instruments such as Europlasma Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Europlasma in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Precious Metals Thematic Idea Now
Precious Metals
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Precious Metals theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Precious Metals Theme or any other thematic opportunities.
View All Next | Launch |
Additional Tools for Europlasma Stock Analysis
When running Europlasma's price analysis, check to measure Europlasma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Europlasma is operating at the current time. Most of Europlasma's value examination focuses on studying past and present price action to predict the probability of Europlasma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Europlasma's price. Additionally, you may evaluate how the addition of Europlasma to your portfolios can decrease your overall portfolio volatility.